Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study.

MLA

Lu, Wen, et al. “Serologic Reactivity of Unidentified Specificity in Antenatal Testing and Hemolytic Disease of the Fetus and Newborn: The BEST Collaborative Study.” Transfusion, vol. 63, no. 4, Apr. 2023, pp. 817–25. EBSCOhost, https://doi.org/10.1111/trf.17276.

APA

Lu, W., Ziman, A., Yan, M. T. S., Waters, A., Virk, M. S., Tran, A., Tang, H., Shih, A. W., Scally, E., Raval, J. S., Pandey, S., Pagano, M. B., Shan, H., Moore, C., Morrison, D., Cormack, O., Fitzgerald, J., Duncan, J., Corean, J., … Yazer, M. (2023). Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study. Transfusion, 63(4), 817–825. https://doi.org/10.1111/trf.17276

Chicago

Lu, Wen, Alyssa Ziman, Matthew T S Yan, Allison Waters, Mrigender Singh Virk, Ann Tran, Hongying Tang, et al. 2023. “Serologic Reactivity of Unidentified Specificity in Antenatal Testing and Hemolytic Disease of the Fetus and Newborn: The BEST Collaborative Study.” Transfusion 63 (4): 817–25. doi:10.1111/trf.17276.